辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PFE 辉瑞

交易中 02-24 13:07:20 EST

27.27

+0.21

+0.76%

最高27.42	最低27.13	成交量1,294万
今开27.13	昨收27.06	日振幅1.07%
总市值1,550亿	流通市值1,548亿	总股本56.86亿
成交额3.53亿	换手率0.23%	流通股本56.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":27.265,"timestamp":1771956439098,"preClose":27.06,"halted":0,"volume":12938469,"delay":0,"changeRate":0.0075757575757576445,"floatShares":5675908374,"shares":5685707552,"eps":1.36,"marketStatus":"交易中","change":0.205,"latestTime":"02-24 13:07:20 EST","open":27.13,"high":27.42,"low":27.13,"amount":353152354.368564,"amplitude":0.010717,"askPrice":27.27,"askSize":8105,"bidPrice":27.26,"bidSize":2312,"shortable":3,"etf":0,"ttmEps":1.36,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":27.06,"dividendRate":0.063121,"preHourTrading":{"tag":"盘前","latestPrice":27.16,"preClose":27.06,"latestTime":"09:29 EST","volume":56933,"amount":1542714.810459,"timestamp":1771943385523,"change":0.1,"changeRate":0.003695,"amplitude":0.006652},"postHourTrading":{"tag":"盘后","latestPrice":27.03,"preClose":27.06,"latestTime":"19:59 EST","volume":4162544,"amount":112638699.7375,"timestamp":1771894797568,"change":-0.03,"changeRate":-0.001109,"amplitude":0.005174},"volumeRatio":0.656947,"optionData":{"bulkOrders":[{"symbol":"PFE","call":false,"expireDate":1789704000000,"strike":"24.0","timestamp":1771952574027,"price":0.83,"volume":7582,"amount":629306,"type":"+"},{"symbol":"PFE","call":false,"expireDate":1773979200000,"strike":"25.0","timestamp":1771949738909,"price":0.09,"volume":4500,"amount":40500,"type":"-"}]},"impliedVol":0.2601,"impliedVolPercentile":0.255},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"2613110762","title":"豪掷近5亿美元辉瑞(PFE.US)牵手中国biotech，加码在华减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2613110762","media":"智通财经","labels":["corporation"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613110762?lang=zh_cn&edition=full","pubTime":"2026-02-24 14:56","pubTimestamp":1771916204,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国制药巨头辉瑞公司与本土初创企业杭州先为达生物科技股份有限公司达成协议，以获得后者一款减肥疗法在中国的独家商业化权益，此举旨在强化其在高增长减肥市场的布局。该药近期在中国获批用于治疗糖尿病，目前其用于减肥的适应症正处于监管审查阶段。辉瑞一直大力追赶在减肥药领域的领先者。辉瑞正寻求在后疫情时代进行业务重建。在中国减肥药市场，辉瑞将直面全球制药巨头及信达生物等本土竞争对手的挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"豪掷近5亿美元辉瑞(PFE.US)牵手中国biotech，加码在华减肥药市场","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0985481810.HKD","LU0306806265.USD","LU1057294990.SGD","BK4550","BK4581","LU1066053197.SGD","LU1894683264.USD","BK4533","BK4588","IE0002270589.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","IE00BLSP4239.USD","SG9999013999.USD","SG9999011175.SGD","LU0321505439.SGD","LU0868494617.USD","BK4592","BK4599","BK4534","LU1023059063.AUD","BK4007","SG9999002232.USD","IE00B19Z3581.USD","LU0122379950.USD","LU0321505868.SGD","LU1066051498.USD","IE00BBT3K403.USD","SG9999003800.SGD","SG9999001176.SGD","SGXZ57979304.SGD","LU0225284248.USD","BK4568","IE000M9KFDE8.USD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999001176.USD","LU0170899867.USD","LU0234572021.USD","BK4585","LU1883839398.USD","LU0058720904.USD","PFE","SG9999002224.SGD","LU1894683348.USD","LU0306807586.USD"],"gpt_icon":1},{"id":"2613897750","title":"先为达生物携手辉瑞中国，达成埃诺格鲁肽商业化战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2613897750","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613897750?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:23","pubTimestamp":1771899780,"startTime":"0","endTime":"0","summary":"2月24日消息，杭州先为达生物科技股份有限公司与辉瑞中国今日宣布，双方就新一代偏向型GLP-1受体激动剂埃诺格鲁肽注射液 达成商业化战略合作协议。先为达生物将有权获得辉瑞支付的最高可达4.95亿美元的付款总额，包括首付款、注册及销售里程碑付款。　　埃诺格鲁肽是由先为达生物自主研发的新一代cAMP偏向型GLP-1受体激动剂，将为2型糖尿病及长期体重管理相关患者提供更为精准的治疗方案。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-24/doc-inhnwrqu6119933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1894683348.USD","LU0058720904.USD","LU0321505439.SGD","BK4585","LU0170899867.USD","BK4581","LU1023059063.AUD","LU0306806265.USD","BK4007","IE00BLSP4239.USD","SG9999001176.USD","PFE","LU0985481810.HKD","BK4599","LU1066053197.SGD","LU0456855351.SGD","IE00B19Z3B42.SGD","LU0321505868.SGD","SG9999011175.SGD","SGXZ57979304.SGD","91078","IE00BBT3K403.USD","IE00BLSP4452.SGD","SG9999001176.SGD","LU0234572021.USD","BK4533","IE000M9KFDE8.USD","LU1066051498.USD","SG9999003800.SGD","SG9999013999.USD","LU0225284248.USD","BK4568","BK4534","BK4588","LU0306807586.USD","LU1883839398.USD","SG9999002232.USD","BK4550","SG9999002224.SGD","LU0122379950.USD","LU0289739699.SGD","LU1057294990.SGD","LU0225771236.USD","IE00B19Z3581.USD","LU1894683264.USD","IE0002270589.USD","LU0868494617.USD","BK4592"],"gpt_icon":1},{"id":"1110833815","title":"杭州Sciwind生物与辉瑞中国就新一代Ecnoglutide注射剂商业化达成战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1110833815","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110833815?lang=zh_cn&edition=full","pubTime":"2026-02-24 09:30","pubTimestamp":1771896617,"startTime":"0","endTime":"0","summary":"杭州Sciwind生物科技公司与辉瑞中国已正式签署战略合作协议，共同推进新一代Ecnoglutide注射剂的商业化进程。此次合作旨在整合双方在研发与市场渠道方面的优势，加速该创新药物在中国市场的应用与推广。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU1066051498.USD","02252","IE00BLSP4239.USD","SG9999002232.USD","SGXZ57979304.SGD","LU0321505439.SGD","LU1883839398.USD","SG9999001176.SGD","BK4585","BK4581","LU0985481810.HKD","LU1894683348.USD","IE00BBT3K403.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0170899867.USD","LU0225284248.USD","IE00B19Z3581.USD","BK4599","LU1894683264.USD","BK4592","SG9999011175.SGD","LU0058720904.USD","LU1066053197.SGD","LU0456855351.SGD","BK4007","BK4534","LU0225771236.USD","LU1023059063.AUD","PFE","LU1057294990.SGD","LU0306806265.USD","LU0289739699.SGD","LU0306807586.USD","BK4533","BK4588","BK4550","IE000M9KFDE8.USD","LU0234572021.USD","BK4568","LU0868494617.USD","SG9999003800.SGD","SG9999013999.USD","LU0321505868.SGD","IE00BLSP4452.SGD","SG9999001176.USD","LU0122379950.USD"],"gpt_icon":0},{"id":"1182484790","title":"辉瑞第四财季净利润达14.2亿卢比","url":"https://stock-news.laohu8.com/highlight/detail?id=1182484790","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182484790?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:49","pubTimestamp":1770648556,"startTime":"0","endTime":"0","summary":"辉瑞有限公司最新财报显示，公司在第四财季实现净利润14.2亿卢比。同期，公司营业收入为64.5亿卢比。财报数据反映出企业当季的盈利能力和运营表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","BK4007","LU0225284248.USD","PFE","SG9999003800.SGD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","BK4599","LU1894683264.USD","LU0985481810.HKD","LU0868494617.USD","SG9999002232.USD","BK4534","LU0321505439.SGD","SG9999001176.SGD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","BK4581","LU1894683348.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU0306807586.USD","LU1066051498.USD","BK4550","SG9999011175.SGD","LU1023059063.AUD","BK4568","LU1066053197.SGD","LU0321505868.SGD","BK4533","LU0306806265.USD","LU0058720904.USD","BK4592","LU0225771236.USD","LU0122379950.USD","SG9999013999.USD","SG9999001176.USD","LU0456855351.SGD","BK4588","IE0002270589.USD","LU0234572021.USD","LU1883839398.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2609591202","title":"辉瑞抗感染创新药获批儿科适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591202","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609591202?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:20","pubTimestamp":1770387607,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BBT3K403.USD","SG9999003800.SGD","IE00BLSP4452.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU0868494617.USD","LU0289739699.SGD","LU1066051498.USD","IE00BLSP4239.USD","LU0225771236.USD","IE000M9KFDE8.USD","BK4550","PFE","LU1066053197.SGD","IE00B19Z3581.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0985481810.HKD","SG9999001176.SGD","LU1057294990.SGD","LU0122379950.USD","LU0306806265.USD","LU0225284248.USD","LU0456855351.SGD","LU0058720904.USD","LU0321505439.SGD","LU0306807586.USD","BK4568","LU1894683264.USD","BK4599","LU1894683348.USD","LU0321505868.SGD","BK4007","BK4585","BK4534","BK4581","BK1574","BK4588","SG9999001176.USD","BK1161","BK4592","LU1883839398.USD","SG9999013999.USD","SG9999002232.USD","IE0002270589.USD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4533"],"gpt_icon":0},{"id":"1119071271","title":"FDA授予Hympavzi®（Marstacimab）优先审评资格，用于治疗存在重大医疗需求的两类血友病A或B患者群体","url":"https://stock-news.laohu8.com/highlight/detail?id=1119071271","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119071271?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:45","pubTimestamp":1770378357,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已授予Hympavzi®（Marstacimab）补充生物制剂许可申请（sBLA）优先审评资格。该药物旨在治疗存在重大医疗需求的两类血友病A或B患者群体。\n优先审评资格的授予，意味着FDA认为该疗法有潜力在安全性或有效性方面为患者提供显著改善。此举有望加速Hympavzi®的审批进程，为亟需新治疗选择的血友病患者带来希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4592","IE00B19Z3581.USD","LU0985481810.HKD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0170899867.USD","LU0289739699.SGD","LU0456855351.SGD","BK4534","SG9999011175.SGD","IE0002270589.USD","IE000M9KFDE8.USD","SG9999002224.SGD","LU1894683264.USD","BK4007","LU0306806265.USD","SG9999013999.USD","LU1894683348.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","SG9999001176.SGD","SG9999002232.USD","BK4588","PFE","LU0225284248.USD","BK4550","LU0058720904.USD","IE00BLSP4239.USD","LU1883839398.USD","SG9999003800.SGD","LU0321505439.SGD","IE00BBT3K403.USD","LU1066051498.USD","LU0868494617.USD","SG9999001176.USD","LU1023059063.AUD","LU1057294990.SGD","BK4533","LU0306807586.USD","LU0321505868.SGD","BK4568","SGXZ57979304.SGD","LU0225771236.USD","BK4599","BK4581"],"gpt_icon":0},{"id":"1191151847","title":"辉瑞推出优惠计划：覆盖女性健康、偏头痛、关节炎及罕见病等30多个品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1191151847","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191151847?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:14","pubTimestamp":1770336852,"startTime":"0","endTime":"0","summary":"辉瑞公司近日宣布推出一项新的优惠计划，该计划涵盖超过30个品牌，涉及女性健康、偏头痛、关节炎、罕见疾病等多个治疗领域。通过这一计划，患者有望在购买相关药物时获得费用节省。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","BK4592","LU0306806265.USD","LU0306807586.USD","SG9999003800.SGD","BK4568","BK4581","LU0868494617.USD","SG9999001176.USD","IE0002270589.USD","SG9999002224.SGD","LU0122379950.USD","BK4007","SG9999002232.USD","IE00BBT3K403.USD","BK4588","LU0225771236.USD","LU0170899867.USD","LU1057294990.SGD","BK4599","LU1894683348.USD","SGXZ57979304.SGD","PFE","BK4534","IE00B19Z3B42.SGD","LU0234572021.USD","LU0289739699.SGD","BK4585","LU0321505868.SGD","LU0225284248.USD","LU0321505439.SGD","SG9999013999.USD","LU0985481810.HKD","LU1023059063.AUD","IE000M9KFDE8.USD","LU0058720904.USD","IE00BLSP4239.USD","LU1066053197.SGD","SG9999001176.SGD","BK4550","LU1066051498.USD","LU1894683264.USD","LU0456855351.SGD","LU1883839398.USD","BK4533","SG9999011175.SGD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2608952381","title":"辉瑞(PFE.US)超长效减重疗法取得积极顶线结果 将启动3期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2608952381","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608952381?lang=zh_cn&edition=full","pubTime":"2026-02-04 07:53","pubTimestamp":1770162821,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月3日，辉瑞宣布，其超长效注射用GLP-1受体激动剂PF'3944在2b期VESPER-3研究中取得积极顶线结果。该研究针对肥胖或超重、不合并2型糖尿病的成人患者，评估每月一次维持给药方案。结果显示，治疗第28周，第1组和第3组患者的体重分别较安慰剂组降低了10%和12.3%。安慰剂组中没有因AEs而中止治疗的情况。辉瑞计划推进大规模肥胖开发项目，预计在2026年启动20项以上临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"辉瑞(PFE.US)超长效减重疗法取得积极顶线结果 将启动3期试验","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0225284248.USD","LU0170899867.USD","BK4533","BK4585","SG9999001176.USD","BK4534","LU0321505439.SGD","BK4007","SG9999003800.SGD","LU0306807586.USD","LU1057294990.SGD","LU1066051498.USD","LU0985481810.HKD","IE00BBT3K403.USD","BK4568","BK4550","LU1894683264.USD","SG9999002224.SGD","SG9999002232.USD","IE00B19Z3581.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0868494617.USD","SG9999001176.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","SGXZ57979304.SGD","BK4581","LU0321505868.SGD","LU0234572021.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0058720904.USD","BK4588","LU0225771236.USD","IE0002270589.USD","LU1066053197.SGD","LU1883839398.USD","LU1894683348.USD","SG9999013999.USD","PFE","LU0456855351.SGD","SG9999011175.SGD","BK4599","LU1023059063.AUD","BK4592"],"gpt_icon":1},{"id":"2608114387","title":"超1/3大额并购配置CVR，对赌因何活跃？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608114387","media":"研发客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608114387?lang=zh_cn&edition=full","pubTime":"2026-02-04 05:00","pubTimestamp":1770152451,"startTime":"0","endTime":"0","summary":"改变打法据BioPharma Dive统计，2025年下半年，约有三分之一的大额并购交易采用了CVR模式。交易条款包括每股65.60美元的固定现金对价，以及最高每股20.65美元的CVR款项。CVR 与未来里程碑达成情况挂钩，仅当相关目标按期实现时，收购方才需支付该笔额外款项。Genmab在竞购的过程中更是明确表示对CVR不感兴趣，希望以一次性付款的方式完成交易。此外，德勤的调查发现，45%的生物制药领导者将并购列为近期的首要战略重点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204050313a478cb18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204050313a478cb18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4161","LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","JNJ","IE00BKVL7J92.USD","NVO","PFE","BK4599","BK4532","BK4588","LU1093756168.USD","BK4585","LU1093756325.SGD","RHHBY"],"gpt_icon":1},{"id":"2608808896","title":"辉瑞CEO表示，公司计划在2026年开展约20项与减肥药相关的临床试验。","url":"https://stock-news.laohu8.com/highlight/detail?id=2608808896","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608808896?lang=zh_cn&edition=full","pubTime":"2026-02-03 23:14","pubTimestamp":1770131691,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BLSP4452.SGD","LU0868494617.USD","IE0002270589.USD","BK4550","IE00B19Z3581.USD","SG9999011175.SGD","BK4581","BK4585","SG9999002232.USD","LU0170899867.USD","BK4533","LU1883839398.USD","BK4568","BK4599","LU1057294990.SGD","PFE","LU1066053197.SGD","LU0321505439.SGD","SGXZ57979304.SGD","LU0321505868.SGD","SG9999001176.SGD","LU0985481810.HKD","LU1023059063.AUD","LU1894683264.USD","LU0225284248.USD","SG9999001176.USD","IE00BBT3K403.USD","BK4534","LU0122379950.USD","LU0456855351.SGD","SG9999013999.USD","SG9999002224.SGD","BK4592","LU0225771236.USD","LU0058720904.USD","BK4588","LU0306806265.USD","BK4007","LU0234572021.USD","IE00B19Z3B42.SGD","LU1066051498.USD","IE00BLSP4239.USD","SG9999003800.SGD","LU0306807586.USD","IE000M9KFDE8.USD","LU1894683348.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2608587944","title":"药品需求旺盛，辉瑞四季度利润超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2608587944","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608587944?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:08","pubTimestamp":1770124080,"startTime":"0","endTime":"0","summary":"专题：聚焦美股2025年第四季度财报\n　　辉瑞于周二公布四季度业绩，公司利润超华尔街预期，业绩增长得益于阿哌沙班、维达全这类经典药物的需求持续走高。\n　　据伦敦证券交易所集团汇总的数据，经调整后，辉瑞四季度每股收益为 66 美分，高于分析师此前 57 美分的预期。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4466d9e38820302c3ea1a8f2a1598904","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-03/doc-inhkpzpa3613400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1894683264.USD","LU0122379950.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0868494617.USD","BK4585","BK4568","LU0456855351.SGD","BK4550","IE00BLSP4239.USD","SG9999002224.SGD","BK4592","LU1883839398.USD","LU1023059063.AUD","LU1066051498.USD","LU1894683348.USD","BK4534","LU0321505439.SGD","IE00BLSP4452.SGD","LU0985481810.HKD","LU0289739699.SGD","BK4533","LU0321505868.SGD","LU0234572021.USD","SG9999001176.USD","SG9999001176.SGD","LU0058720904.USD","BK4007","BK4581","LU0170899867.USD","LU1057294990.SGD","SG9999002232.USD","LU0306806265.USD","IE0002270589.USD","PFE","BK4599","SG9999013999.USD","BK4588","IE00BBT3K403.USD","LU1066053197.SGD","LU0225771236.USD","SG9999011175.SGD","LU0306807586.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999003800.SGD","LU0225284248.USD"],"gpt_icon":0},{"id":"2608787921","title":"辉瑞(PFE.US)Q4业绩超预期 但投资者更关注减肥药能否扛起增长大旗","url":"https://stock-news.laohu8.com/highlight/detail?id=2608787921","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608787921?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:06","pubTimestamp":1770123978,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，辉瑞公布了第四季度财报，尽管新冠相关产品需求持续萎缩，但公司营收与利润仍双双超出市场预期，同时公司重申了2026年的温和指引——该指引在去年12月公布时曾引发投资者担忧。另外，辉瑞还公布了其新型减肥疗法的初步数据，但披露信息有限。作为交换，辉瑞将获得为期三年的关税豁免。不过，在财报公布后，辉瑞股价盘前仍跌逾5%。他认为，辉瑞需要凭借在疗效或安全性上显著更优的产品，才能在该领域立足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4466d9e38820302c3ea1a8f2a1598904","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE000M9KFDE8.USD","SG9999001176.SGD","BK4599","BK4581","LU0868494617.USD","BK4533","BK4007","IE00BLSP4239.USD","LU0225771236.USD","SG9999001176.USD","PFE","LU0306807586.USD","LU0985481810.HKD","IE0002270589.USD","LU1066053197.SGD","BK4585","BK4534","LU1894683264.USD","LU0456855351.SGD","BK4568","LU0225284248.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0321505868.SGD","LU1057294990.SGD","SG9999002224.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0122379950.USD","SG9999013999.USD","IE00B19Z3581.USD","LU1883839398.USD","LU1894683348.USD","SG9999011175.SGD","BK4592","LU0306806265.USD","BK4588","LU0321505439.SGD","LU1066051498.USD","BK4550","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0170899867.USD","LU1023059063.AUD","LU0234572021.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"1182267894","title":"周二值得关注的股票：PayPal、百事可乐、美国超微公司——华尔街日报","url":"https://stock-news.laohu8.com/highlight/detail?id=1182267894","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182267894?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:37","pubTimestamp":1770122252,"startTime":"0","endTime":"0","summary":"辉瑞最新财报显示，这家制药巨头季度销售额出现下滑，并意外录得亏损，主要因其新冠疫苗和抗病毒药物的市场需求持续萎缩。盘前交易中，该公司股价下跌约1%。PayPal预警称，由于核心品牌结算业务增长乏力，今年盈利可能面临下滑。该公司同时宣布，惠普首席执行官恩里克·洛雷斯将于三月接任PayPal CEO一职。消息公布后，其股价在盘前暴跌15%。美国超微公司与亿滋等企业将于美股收盘后公布业绩。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1116320737.USD","MRK","LU2360107325.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU0661504455.SGD","LU1023059063.AUD","LU2355687059.USD","BK4581","LU1035773651.USD","LU1861214812.USD","LU0162691827.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU1989764664.SGD","PYPY","LU0985320562.USD","LU1989771016.USD","LU0553294199.USD","BK4554","BK4504","BK4566","LU1992135399.USD","IE00BBT3K403.USD","LU1037948897.HKD","LU1244550577.SGD","LU1929549753.HKD","LU0648001328.SGD","LU2272731782.SGD","IE00BQXX3D17.EUR","LU1934455863.HKD","IE00B1BXHZ80.USD","AMUU","LU0719512351.SGD","LU1003077747.HKD","LU1585245621.USD","IE0009356076.USD","LU0320765489.SGD","LU0211331839.USD","LU0266013472.USD","LU2089283258.USD","IE00BQXX3C00.GBP","LU0208291251.USD","LU0321505439.SGD","BK4575","PYPG","LU0306806265.USD","LU0949170772.SGD","LU2360106780.USD","LU0545039389.USD","IE00BFTCPJ56.SGD","LU1046421795.USD","LU0122379950.USD","LU1989772923.USD","SGXZ57979304.SGD","BK4170","SG9999001176.USD","IE0002270589.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU1823568750.SGD","BK4568","DAMD","BK4212","LU0158827948.USD","LU1093756325.SGD","LU0306807586.USD","AMDU","BK4543","LU1069347547.HKD","LU2054465674.USD","LU1923623000.USD","LU0980610538.SGD","LU1883839398.USD","LU1244550494.USD","LU0082616367.USD","LU0274383776.USD","LU2125154778.USD","LU2458330243.SGD","BK4605","IE00B19Z3B42.SGD","LU0098860793.USD","LU1861220207.SGD","AMDY","LU1280957306.USD","LU1861559042.SGD","AMYY","LU1934455194.USD","LU2361044949.HKD","IE00B5949003.HKD","IE00BLSP4452.SGD","LU1057294990.SGD","BK4177","LU0203345920.USD","BK4524","LU1291159041.SGD","LU2250418816.HKD","IE00BSNM7G36.USD","LU1880398471.USD","LU1992135472.HKD","MDLZ","LU2360032135.SGD","LU1974910355.USD","LU0238689110.USD","LU1201861249.SGD","LU2361045086.USD","LU2023251221.USD","LU1242518857.USD","LU0965509283.SGD","LU1668664300.SGD","LU1803068979.SGD","LU2361044865.SGD","LU0058720904.USD","LU1894683264.USD","LU0072461881.USD","LU0265550946.USD","LU0348723411.USD","LU1934455277.USD","LU2931357623.SGD","LU1791807156.HKD","LU2098885051.SGD","AMDW","BK4512","LU0203347892.USD","LU2360107671.USD","SG9999015358.SGD","LU0127658192.USD","BK4529","BK4533","LU0823421416.USD","LU0642271901.SGD","LU0868494617.USD","SG9999015341.SGD","AMDL","SG9999002224.SGD","BK4535","LU1571399168.USD","LU2023250504.SGD","LU1066051811.HKD","LU0985481810.HKD","LU0006061336.USD","LU1861558580.USD","LU1162221912.USD","LU1316542783.SGD","LU1951200564.SGD","LU0477156953.USD","LU2458330169.SGD","SG9999013999.USD","SG9999014542.SGD","LU1699723380.USD","BK4559","LU0006306889.USD","LU0979878070.USD","LU0130102774.USD","LU0130517989.USD","LU1989772840.SGD","LU2468319806.SGD","LU1066051225.USD","BK4527","AMDG","LU0289960550.SGD","IE00BLSP4239.USD","SG9999014559.SGD","LU1066051498.USD","LU2089984988.USD","BK4585","LU0889565833.HKD","LU0225284248.USD","LU1244550221.USD","LU0823434740.USD","LU0320765646.SGD","LU2324357040.USD","BK4588","BK4007","LU2461242641.AUD","LU2125154935.USD","BK4598","LU1093756168.USD","LU1861217088.USD","LU2272731600.USD","LU2089985449.USD","LU1941712348.USD","IE00BZ199S13.USD","LU1880398554.USD","IE0009355771.USD","LU0070302665.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2112291526.USD","IE00B19Z3581.USD","BK4141","IE00BMPRXR70.SGD","BK4614","LU0965508806.USD","IE0004445239.USD","LU1303367103.USD","PYPL","LU0738911758.USD","LU0390134368.USD","LU1037948541.HKD","LU0109392836.USD","LU1852331112.SGD","IE00BQXX3F31.USD","LU0170899867.USD","SG9999001440.SGD","LU1951198990.SGD","LU2089284900.SGD","NXPI","IE00BN8TJ469.HKD","BK4599","AMDD","LU0011850046.USD","LU0198837287.USD","LU1718418525.SGD","LU1917777945.USD","BK4592","LU1988902786.USD","LU0106831901.USD","BK4534","LU2106854487.HKD","LU0081259029.USD","LU0106261372.USD","LU1066053197.SGD","LU1894683348.USD","LU0861579265.USD","LU0965509010.AUD","LU0432979614.USD","IE00BD6J9T35.USD","IE00BMPRXN33.USD","LU0823434583.USD","SG9999014575.USD","LU1064131342.USD","SG9999002232.USD","BK4106","BK4612","LU0265550359.USD","LU1983299246.USD","PEP","BK4573","IE00B3T34201.USD","LU0289739699.SGD","LU1061106388.HKD","PFE","LU2023250843.SGD","LU2247934214.USD","LU1941712264.USD","LU0225771236.USD","IE000M9KFDE8.USD","BK4604","BK4505","BK4516","LU2264538146.SGD","SG9999014567.USD","LU1242518931.SGD","SG9999003800.SGD","BK4227","LU1116320901.HKD","LU2133065610.SGD","LU0321505868.SGD","AMD","BK4561","LU0823421333.USD","BK4551","LU0056508442.USD","LU0175139822.USD","BK4550","LU0965509101.SGD","SG9999011175.SGD","LU1861219969.SGD","LU0640476718.USD","BK4532"],"gpt_icon":1},{"id":"2608687301","title":"辉瑞公布GLP-1新药数据：可实现稳定减重","url":"https://stock-news.laohu8.com/highlight/detail?id=2608687301","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608687301?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:02","pubTimestamp":1770120163,"startTime":"0","endTime":"0","summary":"南方财经2月3日电，辉瑞公司2月3日公布了其超长效注射型GLP-1受体激动剂PF-08653944的最新2b期临床研究结果。数据显示，在为期28周的试验中，该药物表现出显著的减重效果，经安慰剂对照调整后的平均减重幅度达12.3%。辉瑞称，该研究达到了主要终点，且在转为每月给药一次的方案后，患者体重仍持续下降。在安全性方面，该药物表现良好，副作用主要集中在轻度至中度的胃肠道反应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3bb44f7c125c909d9d8be6d6af593a67","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602033640312952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0306806265.USD","LU0321505439.SGD","IE00BLSP4452.SGD","SG9999001176.SGD","BK4599","LU0225284248.USD","BK4592","IE000M9KFDE8.USD","BK4590","SG9999001176.USD","SG9999011175.SGD","BK4007","LU0170899867.USD","LU0868494617.USD","PFE","SG9999002224.SGD","LU1057294990.SGD","LU0289739699.SGD","LU0985481810.HKD","SG9999013999.USD","LU1023059063.AUD","BK4144","BK4581","IE00BLSP4239.USD","LU0225771236.USD","SG9999003800.SGD","BK4534","BK4568","LU1066051498.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1066053197.SGD","BK4585","LU0058720904.USD","IE00BBT3K403.USD","LU0456855351.SGD","BK4550","BK4533","LU0234572021.USD","SGXZ57979304.SGD","LU1894683264.USD","LU1894683348.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999002232.USD","BK4588","LU0306807586.USD","LU0122379950.USD","LU0321505868.SGD"],"gpt_icon":0},{"id":"1113666536","title":"辉瑞预计制造优化计划将在2026年和2027年分别额外节省7亿美元和2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113666536","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113666536?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:59","pubTimestamp":1770119954,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其制造优化计划预计将在2026年实现额外7亿美元的节省，并在2027年进一步节省2亿美元。这一举措旨在提升运营效率并优化成本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU0170899867.USD","BK4533","BK4585","SG9999001176.USD","BK4534","LU0321505439.SGD","BK4007","SG9999003800.SGD","LU0306807586.USD","LU1057294990.SGD","LU1066051498.USD","LU0985481810.HKD","IE00BBT3K403.USD","BK4568","BK4550","LU1894683264.USD","SG9999002224.SGD","SG9999002232.USD","IE00B19Z3581.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0868494617.USD","SG9999001176.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","SGXZ57979304.SGD","BK4581","LU0321505868.SGD","LU0234572021.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU0058720904.USD","BK4588","LU0225771236.USD","IE0002270589.USD","LU1066053197.SGD","LU1883839398.USD","LU1894683348.USD","SG9999013999.USD","PFE","LU0456855351.SGD","SG9999011175.SGD","BK4599","LU1023059063.AUD","BK4592"],"gpt_icon":0},{"id":"1170163241","title":"辉瑞预期制造优化计划首阶段将在2026年额外节省7亿美元、2027年再省2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170163241","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170163241?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:58","pubTimestamp":1770119883,"startTime":"0","endTime":"0","summary":"根据最新公布的规划，全球制药巨头辉瑞公司宣布，其制造优化计划的第一阶段预计将带来显著成本效益：2026年将实现额外节约7亿美元，2027年将进一步节省2亿美元。这项系统性增效举措将聚焦生产流程重构与资源配置优化，通过技术升级和运营整合提升整体效率。\n该战略部署延续了企业持续降本增效的路径，在应对行业挑战的同时强化供应链韧性。阶段性成果的披露为投资者提供了明确的财务指引，也反映出公司通过结构性改革提升长期竞争力的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU1883839398.USD","LU0289739699.SGD","LU1066053197.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","SG9999003800.SGD","LU1894683264.USD","LU1066051498.USD","BK4599","LU0225284248.USD","SGXZ57979304.SGD","BK4588","LU0170899867.USD","BK4533","BK4568","LU0234572021.USD","LU0321505439.SGD","BK4007","IE00BLSP4239.USD","SG9999011175.SGD","LU0306806265.USD","IE00BBT3K403.USD","LU0321505868.SGD","LU0058720904.USD","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4585","IE00BLSP4452.SGD","LU1023059063.AUD","BK4534","SG9999001176.SGD","LU0985481810.HKD","BK4550","SG9999013999.USD","LU0122379950.USD","LU1894683348.USD","SG9999001176.USD","LU0225771236.USD","SG9999002232.USD","LU0306807586.USD","PFE","BK4581","BK4592","IE0002270589.USD","LU1057294990.SGD","LU0456855351.SGD"],"gpt_icon":0},{"id":"2608587335","title":"辉瑞股价盘前下跌2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608587335","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608587335?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:54","pubTimestamp":1770119673,"startTime":"0","endTime":"0","summary":"辉瑞股价盘前下跌2.1%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602033640308628.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"4466d9e38820302c3ea1a8f2a1598904","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602033640308628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4550","LU0289739699.SGD","LU1023059063.AUD","SG9999011175.SGD","BK4599","SG9999003800.SGD","IE00B19Z3B42.SGD","BK4581","BK4592","BK4585","IE0002270589.USD","LU0225771236.USD","LU0306806265.USD","LU0122379950.USD","LU1066051498.USD","LU0321505439.SGD","SG9999002232.USD","LU0306807586.USD","LU1894683348.USD","BK4534","PFE","IE00BLSP4239.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU0058720904.USD","LU0456855351.SGD","LU0321505868.SGD","LU1066053197.SGD","BK4588","LU0225284248.USD","BK4007","SG9999002224.SGD","LU1883839398.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU1057294990.SGD","BK4533","LU1894683264.USD","IE00BLSP4452.SGD","BK4568","LU0234572021.USD","LU0868494617.USD","LU0170899867.USD","LU0985481810.HKD","IE00B19Z3581.USD","SG9999013999.USD"],"gpt_icon":0},{"id":"1163164652","title":"辉瑞高管称肥胖研究数据提示更高剂量或可提升疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1163164652","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163164652?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:53","pubTimestamp":1770119608,"startTime":"0","endTime":"0","summary":"辉瑞公司高管表示，最新肥胖症研究数据显示，通过增加药物剂量有望实现更优疗效。这一发现为体重管理疗法的剂量优化提供了关键科学依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0225284248.USD","BK4568","IE00BLSP4239.USD","LU0289739699.SGD","LU1883839398.USD","LU1057294990.SGD","BK4007","IE00BBT3K403.USD","BK4550","BK4599","LU1023059063.AUD","PFE","BK4533","LU1066053197.SGD","LU0306807586.USD","BK4581","LU1894683264.USD","LU0321505439.SGD","SG9999001176.USD","SG9999013999.USD","BK4588","LU0122379950.USD","SG9999011175.SGD","LU0985481810.HKD","LU0058720904.USD","LU0456855351.SGD","LU0225771236.USD","SG9999001176.SGD","LU0234572021.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","BK4534","LU0170899867.USD","SG9999003800.SGD","BK4585","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999002224.SGD","SG9999002232.USD","LU0321505868.SGD","LU0306806265.USD","BK4592","IE00BLSP4452.SGD","LU1894683348.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"1140905974","title":"辉瑞：按计划到2026年底将实现预期72亿美元总净成本节省的大部分","url":"https://stock-news.laohu8.com/highlight/detail?id=1140905974","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140905974?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:53","pubTimestamp":1770119589,"startTime":"0","endTime":"0","summary":"辉瑞公司宣布，其生产力提升项目正稳步推进，预计到2026年末将实现总计72亿美元的总净成本节约目标中的绝大部分。这一进展凸显了公司通过优化运营效率、强化资源配置来提升盈利能力的战略部署。通过系统性的成本管控与流程革新，辉瑞致力于在保持研发投入与市场扩张的同时，显著改善财务结构，为长期增长注入韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0868494617.USD","LU0058720904.USD","BK4592","IE0002270589.USD","SG9999002232.USD","BK4534","LU0170899867.USD","LU1066051498.USD","SG9999011175.SGD","BK4550","LU1057294990.SGD","SGXZ57979304.SGD","BK4568","LU0321505868.SGD","SG9999003800.SGD","BK4533","PFE","IE00B19Z3581.USD","BK4007","SG9999001176.SGD","LU1883839398.USD","BK4599","LU0306806265.USD","LU0225771236.USD","LU0985481810.HKD","LU1894683348.USD","BK4585","LU0225284248.USD","SG9999001176.USD","SG9999013999.USD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0321505439.SGD","SG9999002224.SGD","BK4588","IE00BLSP4452.SGD","BK4581","IE00BBT3K403.USD","LU1894683264.USD","LU1066053197.SGD","LU0456855351.SGD","LU0122379950.USD","LU0306807586.USD","LU0289739699.SGD","LU0234572021.USD"],"gpt_icon":0},{"id":"1197711025","title":"辉瑞2026年业绩指引受“最惠国”药价政策与Trumprx双重冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=1197711025","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197711025?lang=zh_cn&edition=full","pubTime":"2026-02-03 19:48","pubTimestamp":1770119310,"startTime":"0","endTime":"0","summary":"辉瑞公司最新发布的2026年财务展望显示，其业绩预期已计入\"最惠国\"药品定价政策与Trumprx项目带来的双重不利影响。这一预测反映出制药行业在政策环境变化下面临的严峻挑战。\n作为全球制药巨头，辉瑞在制定长期战略时不得不考虑这些外部因素的叠加效应。其中，\"最惠国\"定价机制可能导致药品价格下行压力，而Trumprx项目的影响则涉及更广泛的市场格局变化。\n尽管面临短期压力，该公司仍通过产品管线优化和成本控制措施维持战略定力。行业观察人士指出，如何平衡政策风险与创新投入将成为辉瑞未来发展的关键课题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999001176.USD","BK4568","SG9999002232.USD","BK4534","LU0868494617.USD","LU1057294990.SGD","LU1894683264.USD","LU0321505868.SGD","BK4599","LU0225284248.USD","PFE","SG9999001176.SGD","LU0122379950.USD","BK4588","IE00BLSP4452.SGD","SG9999013999.USD","LU0058720904.USD","IE00B19Z3581.USD","BK4533","LU0289739699.SGD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0170899867.USD","BK4007","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","LU1894683348.USD","LU0234572021.USD","LU0306806265.USD","IE00BLSP4239.USD","SG9999002224.SGD","BK4581","SG9999003800.SGD","LU0306807586.USD","LU1066051498.USD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":0.055},{"period":"3month","weight":0.0521},{"period":"6month","weight":0.0794},{"period":"1year","weight":0.0289},{"period":"ytd","weight":0.0867}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.456522,"avgChangeRate":0.002542},{"month":2,"riseRate":0.456522,"avgChangeRate":-0.006419},{"month":3,"riseRate":0.6,"avgChangeRate":0.014714},{"month":4,"riseRate":0.586957,"avgChangeRate":0.018253},{"month":5,"riseRate":0.5,"avgChangeRate":0.007748},{"month":6,"riseRate":0.5,"avgChangeRate":0.002798},{"month":7,"riseRate":0.478261,"avgChangeRate":0.011357},{"month":8,"riseRate":0.456522,"avgChangeRate":0.0002},{"month":9,"riseRate":0.456522,"avgChangeRate":0.004432},{"month":10,"riseRate":0.630435,"avgChangeRate":0.013042},{"month":11,"riseRate":0.695652,"avgChangeRate":0.028255},{"month":12,"riseRate":0.5,"avgChangeRate":0.008452}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}